Walvax BioTech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Walvax Biotechnology Co Ltd (300142)
The Walvax share price today is 12.92, view SZ 300142 stock exchange data. Track the latest Walvax share price with real-time updates on 300142 stock performance including market cap, day range, 52-week range and dividend yield. Access 300142 charts, earnings dates and analyst estimates to support your investment decisions.
Shenzhen
Currency in CNY
12.92
+0.07(+0.54%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.60
12.97
52 wk Range
10.88
16.97
Earnings results expected in 10 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.6012.97
52 wk Range
10.8816.97
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300142 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Sell
Price Target
7.00
Downside
-45.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Walvax BioTech receives Investment Bank Analyst Rating Update- Investing.com
Pro
Walvax BioTech receives Investment Bank Analyst Rating Update- Investing.com
Pro
Walvax BioTech receives Investment Bank Analyst Rating Update- Investing.com
Pro- Walvax BioTech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Walvax BioTech receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Walvax BioTech receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Walvax BioTech receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Walvax BioTech receives Investment Bank Analyst Rating Update- Investing.com
Pro
Walvax BioTech receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell
Analysts 12-Month Price Target:
Average 7.00
(-45.82% Downside)
Earnings
Latest Release
29-08-2026
EPS / Forecast
-0.04 / 0.11
Revenue / Forecast
390.37M / 695.66M
Compare 300142 to Peers and Sector
Metrics to compare | 300142 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300142PeersSector | |
|---|---|---|---|---|
P/E Ratio | 108.9x | 36.8x | −0.3x | |
PEG Ratio | 0.09 | 0.03 | 0.00 | |
Price/Book | 2.9x | 2.0x | 2.6x | |
Price / LTM Sales | 9.8x | 6.8x | 2.9x | |
Upside (Analyst Target) | −45.5% | 36.5% | 62.0% | |
Fair Value Upside | Unlock | 5.3% | 9.5% | Unlock |
Walvax Biotechnology Co., Ltd., engages in the research and development, manufacture, and distribution of vaccines in China and internationally. Its vaccine portfolio includes recombinant human papillomavirus bivalent, 13-valent pneumococcal polysaccharide conjugate, 23-valent pneumococcal polysaccharide, group ACYW135 meningococcal polysaccharide, group A and C meningococcal polysaccharide, group A and group C meningococcal conjugate, and haemophilus influenzae type b conjugate vaccines, as well as diphtheria, tetanus and acellular pertussis combined vaccine. The company was founded in 2001 and is headquartered in Kunming, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Walvax (300142) Share Price Today?
The Walvax share price today is 12.92.
What is the current Walvax (300142) share price and day range?
As of 20-10-2026, the Walvax share price is 12.92, with a previous close of 12.92. The share price has ranged from 12.60 to 12.97 today, while the 52-week range spans from 10.88 to 16.97.
What Is the Walvax Market Cap?
As of today, Walvax market cap is 20.55B.
Does Walvax Pay Dividends? What's The Current Dividend Yield?
The Walvax dividend yield is 1.2%%.
What Is the Walvax (300142) Share Price Target?
The average 12-month share price target for Walvax is 7.00, with a high estimate of 7 and a low estimate of 7. 0 analysts recommend buying, while 1 suggest selling, with an overall rating of Strong Sell and -45.82% Downside potential.
What Is Walvax's Earnings Per Share (TTM)?
The Walvax EPS (TTM) is 0.12.
When Is the Next Walvax Earnings Date?
Walvax will release its next earnings report on 30-10-2026.
From a Technical Analysis Perspective, Is 300142 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Walvax Trade On?
Walvax is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Walvax?
The stock symbol for Walvax is "300142."
How Many Times Has Walvax Stock Split?
Walvax has split 5 times.
How Many Employees Does Walvax Have?
Walvax has 1981 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.